Literature DB >> 28229232

Comparison of cure rates in women treated with cold-coagulation versus LLETZ cervical treatment for CIN2-3 on pretreatment cervical punch biopsies: a retrospective cohort study.

Dimitrios Papoutsis1, Martyn Underwood2, William Parry-Smith2, Jane Panikkar2.   

Abstract

PURPOSE: To compare the cure rates between women who were treated with cold-coagulation versus large loop excision of the transformation zone (LLETZ) for cervical intraepithelial neoplasia grade 2 (CIN2) or 3 (CIN3) on pretreatment cervical punch biopsies.
METHODS: This was a retrospective cohort study of women having had a single cervical treatment for CIN2 or CIN3 on pretreatment cervical punch biopsies between 2010 and 2011. The cure rates were defined as the absence of any dyskaryosis (mild/moderate/severe) on cytology tests during follow-up and were determined at 6 and 12 months after treatment.
RESULTS: We identified 411 women having had cervical treatment with 178 cases of cold-coagulation and 233 cases of LLETZ. The cure rates at 6 months following cold-coagulation and LLETZ treatment were 91.6 versus 97.1% (p = 0.02), whereas at 12 months, they were 96.5 versus 97.3% (p = 0.76). Multivariable analysis showed that after adjusting for confounding factors, there was a fourfold higher cure rate with LLETZ in comparison with cold-coagulation at 6 months after treatment (adjusted OR 4.50, 95% CI 1.20-16.83; p = 0.026), with this difference disappearing at 12 months. The lower cure rates with cold-coagulation were due to its higher rates of mild dyskaryosis cytology tests at 6 months. The rates of moderate/severe dyskaryosis cytology tests were similar between the two treatment methods at 6 and 12 months.
CONCLUSION: We found that women with CIN2 or CIN3 on pretreatment cervical punch biopsies, after adjusting for multiple confounding factors, had higher cure rates when treated with LLETZ versus cold-coagulation at 6 months, with this difference disappearing at 12 months.

Entities:  

Keywords:  CIN; Cold coagulation; LLETZ

Mesh:

Year:  2017        PMID: 28229232     DOI: 10.1007/s00404-017-4306-z

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  5 in total

1.  The Role of Affordable, Point-of-Care Technologies for Cancer Care in Low- and Middle-Income Countries: A Review and Commentary.

Authors:  Karen Haney; Pushpa Tandon; Rao Divi; Miguel R Ossandon; Houston Baker; Paul C Pearlman
Journal:  IEEE J Transl Eng Health Med       Date:  2017-11-23       Impact factor: 3.316

2.  Healing pattern of the cervical stroma following cold coagulation treatment for cervical intraepithelial neoplasia: A case report.

Authors:  Dimitrios Papoutsis; Joanna Williams; Martyn Underwood; William Parry-Smith
Journal:  Oncol Lett       Date:  2022-01-14       Impact factor: 2.967

Review 3.  Thermal Ablation Treatment for Cervical Precancer (Cervical Intraepithelial Neoplasia Grade 2 or Higher [CIN2+]).

Authors:  Montserrat Soler; Rachel Masch; Rakiya Saidu; Miriam Cremer
Journal:  Methods Mol Biol       Date:  2022

Review 4.  Ablative Therapies for Cervical Intraepithelial Neoplasia in Low-Resource Settings: Findings and Key Questions.

Authors:  Miriam L Cremer; Gabriel Conzuelo-Rodriguez; William Cherniak; Thomas Randall
Journal:  J Glob Oncol       Date:  2018-10

5.  Test of cure and beyond: superiority of thermal ablation over LLETZ in the treatment of high-grade CIN.

Authors:  G M Armstrong; K Ragupathy
Journal:  Arch Gynecol Obstet       Date:  2022-02-02       Impact factor: 2.493

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.